DCBODocebo Inc.
The schedule
- Thu15Oct
Enterprise learning and software budget finalizations for the upcoming calendar year under current corporate tax visibility.
- Fri5Feb
Q3 2026 earnings print, serving as a direct barometer for second-half deal velocity and recurring revenue acceleration.
- Fri7May
First-quarter 2027 earnings release, lapping the severely depressed Q1 2026 comparables.
- Fri7May
Full-year 2026 results and the critical release of FY2027 forward guidance.
Past
- Fri7Aug
DCBO releases Q2 2026 results, facing heavy scrutiny over operating cost pressures and margin defense.
- Tue16Jun
Management updates on the AI product roadmap and addresses recent Q1 profitability concerns at the Annual General Meeting.
- Fri8May
Actual outcome: Bear · $17.40 at outcome
Docebo reported Q1 2026 earnings that met EPS estimates, with management highlighting traction in enterprise and government markets. However, the stock fell sharply following the release as investors remained cautious. Despite commentary about rebounding demand fueled by AI tools, the sell-off reflects lingering concerns over the company's go-to-market execution and the need for its land-and-expand strategy to definitively prove itself.
Q1 2026 Earnings Release assessing top-line momentum and forward guidance against a $18.24 base price, with a target of $21.50 and fallback of $15.50.
